TWD 105.5
(2.93%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 329 Thousand TWD | -74.54% |
2022 | 1.29 Million TWD | 2648.94% |
2021 | 47 Thousand TWD | -33.8% |
2020 | 71 Thousand TWD | 0.0% |
2019 | - TWD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | -5.18 Million TWD | -1.53% |
2023 FY | 329 Thousand TWD | -74.54% |
2023 Q4 | -5.1 Million TWD | -0.79% |
2023 Q2 | -5.06 Million TWD | -13.84% |
2022 Q4 | -4.45 Million TWD | 0.0% |
2022 FY | 1.29 Million TWD | 2648.94% |
2021 FY | 47 Thousand TWD | -33.8% |
2020 FY | 71 Thousand TWD | 0.0% |
2019 FY | - TWD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
SYN-TECH Chem. & Pharm. Co., Ltd. | 402.54 Million TWD | 99.918% |
Sagittarius Life Science Corp | 71.47 Million TWD | 99.54% |
NeoCore Technology Co., Ltd. | -9.08 Million TWD | 103.621% |
GeneReach Biotechnology Corp. | 27.58 Million TWD | 98.807% |
Genomics BioSci & Tech. Co.,Ltd. | 119.91 Million TWD | 99.726% |
Visgeneer Inc. | 67.48 Million TWD | 99.512% |
Sunmax Biotechnology Co., Ltd. | 1.4 Billion TWD | 99.977% |
G&E Herbal Biotechnology Co., Ltd. | 144.58 Million TWD | 99.772% |
Neith Corporation | 18.01 Million TWD | 98.174% |
TaiwanJ Pharmaceuticals Co., Ltd. | 22.74 Million TWD | 98.553% |
Enimmune corporation | -23.37 Million TWD | 101.408% |
TaiRx, Inc. | 2.43 Million TWD | 86.511% |
EirGenix Inc. | 236.74 Million TWD | 99.861% |
BioLASCO Taiwan Co., Ltd. | 104.35 Million TWD | 99.685% |
Sunny Pharmtech Inc. | 285.52 Million TWD | 99.885% |
BioGend Therapeutics Co., Ltd. | 89.61 Million TWD | 99.633% |
Feng Chi Biotech Corp. | 80.72 Million TWD | 99.592% |
Lukas Biomedical Inc. | 133.89 Million TWD | 99.754% |
RBC Bioscience Corporation | 72.89 Million TWD | 99.549% |
BiOptic Inc. | 152.74 Million TWD | 99.785% |
Shine-On BioMedical Co.,Ltd. | 6.66 Million TWD | 95.065% |
Great Novel Therapeutics Biotech & Medicals | 2.61 Million TWD | 87.419% |
Syngen Biotech Co.,Ltd. | 643.91 Million TWD | 99.949% |
Mycenax Biotech Inc. | -375.19 Million TWD | 100.088% |
Medigen Vaccine Biologics Corporation | 230.22 Million TWD | 99.857% |
Bio Preventive Medicine Corp. | 1.08 Million TWD | 69.621% |
Level Biotechnology Inc. | 219.54 Million TWD | 99.85% |
TaiMed Biologics Inc. | 225.23 Million TWD | 99.854% |
GlycoNex Incorporation | 995 Thousand TWD | 66.935% |
Taiwan Advance Bio-Pharmaceutical Inc. | 198.45 Million TWD | 99.834% |
SynCore Biotechnology Co.,Ltd | 521 Thousand TWD | 36.852% |
Lin BioScience, Inc. | -17.92 Million TWD | 101.835% |
BRIM Biotechnology, Inc. | 90 Thousand TWD | -265.556% |
VBI | 16.42 Million TWD | 97.997% |
CHO Pharma, Inc. | -28.27 Million TWD | 101.163% |
Advagene Biopharma Co., Ltd. | -12 Million TWD | 102.741% |
NaviFUS Corp. | 11.82 Million TWD | 97.218% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 96.77 Million TWD | 99.66% |
Sinew Pharma Inc. | -28.98 Million TWD | 101.135% |
Andros Pharmaceuticals Co.,Ltd | 313 Thousand TWD | -5.112% |
Greenyn Biotechnology Co., Ltd | 392.45 Million TWD | 99.916% |
Lumosa Therapeutics Co., Ltd. | 41.48 Million TWD | 99.207% |
AP Biosciences Inc | 32.25 Million TWD | 98.98% |
Medigen Biotechnology Corp. | 617.32 Million TWD | 99.947% |
3D Global Biotech Inc. | 5.27 Million TWD | 93.762% |
Pharmosa Biopharm Inc. | 314.5 Million TWD | 99.895% |
Intech Biopharm Corporation | -163.99 Million TWD | 100.201% |
Oneness Biotech Co., Ltd. | 32.56 Million TWD | 98.99% |
Eusol Biotech Co.,Ltd. | -4.02 Million TWD | 108.166% |
TWi Biotechnology, Inc. | -9.73 Million TWD | 103.378% |
Ever Supreme Bio Technology Co., Ltd | 484.75 Million TWD | 99.932% |
TCI GENE Inc. | 174.61 Million TWD | 99.812% |
MegaPro Biomedical Co., Ltd | -16.6 Million TWD | 101.982% |
Senhwa Biosciences, Inc. | -10.17 Million TWD | 103.234% |
Taiwan Bio Therapeutics Co., Ltd | 76.35 Million TWD | 99.569% |
NatureWise Biotech & Medicals Corporation | 76.96 Million TWD | 99.573% |
PharmaEngine, Inc. | 718.97 Million TWD | 99.954% |
Savior Lifetec Corporation | 220.94 Million TWD | 99.851% |
TaiGen Biopharmaceuticals Holdings Limited | 111.68 Million TWD | 99.705% |
OBI Pharma, Inc. | -73.49 Million TWD | 100.448% |
Meribank Biotech Co., Ltd | 138.87 Million TWD | 99.763% |
Acepodia, Inc. | 16.59 Million TWD | 98.017% |
Caliway Biopharmaceuticals Co., Ltd. | 27.46 Million TWD | 98.802% |